Mark Robertson-Tessi

Citée par

	Toutes	Depuis 2019
Citations	2178	1771
indice h	25	22
indice i10	32	31

460

230

115

345

2007200820092010201120122013201420152016201720182019202020212022202320246 6 5 9 8 6 21 22 26 58 100 127 158 185 252 305 421 447

Accès public

Tout afficher

34 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Jeffrey WestIntegrated Mathematical Oncology, Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Chandler GatenbeeMoffitt Cancer CenterAdresse e-mail validée de moffitt.org
Kimberly LuddyH. Lee Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Jill GallaherResearch Scientist, Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Maximilian A R StroblPostdoctoral Research Fellow, Cleveland Clinic, USAAdresse e-mail validée de ccf.org
Ryan O. SchenckStanford Cancer Institute; Stanford UniversityAdresse e-mail validée de stanford.edu
Joel S BrownMoffitt Cancer CenterAdresse e-mail validée de darwiniandynamics.org
Mehdi DamaghiAssistant professor at Stony Brook medicine, dept of pathology and SB cancer centerAdresse e-mail validée de stonybrookmedicine.edu
Alain GorielyUniversity of Oxford, Mathematical InstituteAdresse e-mail validée de maths.ox.ac.uk
Heiko EnderlingProfessor, Radiation Oncology, Inst. for Data Science, MD Anderson Cancer Center, Houston, TX, USAAdresse e-mail validée de mdanderson.org
Yoganand (Yoga) BalagurunathanMoffitt Cancer CenterAdresse e-mail validée de moffitt.org
Jan Poleszczuk, PhDNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of SciencesAdresse e-mail validée de mimuw.edu.pl
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKAdresse e-mail validée de icr.ac.uk
Mark LloydInspirata Inc.Adresse e-mail validée de inspirata.com
Jonathan W. WojtkowiakBlueprint Medicines; Previous Moffitt Cancer CenterAdresse e-mail validée de blueprintmedicines.com

Suivre

Mark Robertson-Tessi

Integrated Mathematical Oncology, Moffitt Cancer Center

Adresse e-mail validée de moffitt.org - Page d'accueil


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes M Robertson-Tessi, RJ Gillies, RA Gatenby, ARA Anderson Cancer research 75 (8), 1567-1579, 2015	302	2015
A mathematical model of tumor–immune interactions M Robertson-Tessi, A El-Kareh, A Goriely Journal of theoretical biology 294, 56-73, 2012	184	2012
Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution A Ibrahim-Hashim, M Robertson-Tessi, PM Enriquez-Navas, M Damaghi, ... Cancer research 77 (9), 2242-2254, 2017	134	2017
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer A El-Kenawi, C Gatenbee, M Robertson-Tessi, R Bravo, J Dhillon, ... British journal of cancer 121 (7), 556-566, 2019	130	2019
Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions JT Poleszczuk, KA Luddy, S Prokopiou, M Robertson-Tessi, EG Moros, ... Cancer research 76 (5), 1009-1018, 2016	124	2016
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021	110	2021
The harsh microenvironment in early breast cancer selects for a Warburg phenotype M Damaghi, J West, M Robertson-Tessi, L Xu, MC Ferrall-Fairbanks, ... Proceedings of the National Academy of Sciences 118 (3), e2011342118, 2021	110	2021
Evolutionary dynamics of neoantigens in growing tumors E Lakatos, MJ Williams, RO Schenck, WCH Cross, J Househam, L Zapata, ... Nature genetics 52 (10), 1057-1066, 2020	107	2020
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ... PLoS computational biology 16 (3), e1007635, 2020	91	2020
Elastic growth models A Goriely, M Robertson-Tessi, M Tabor, R Vandiver Mathematical modelling of biosystems, 1-44, 2008	84*	2008
Normal tissue architecture determines the evolutionary course of cancer J West, RO Schenck, C Gatenbee, M Robertson-Tessi, ARA Anderson Nature communications 12 (1), 2060, 2021	76	2021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications medicine 2 (1), 46, 2022	60	2022
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition KA Luddy, M Robertson-Tessi, NK Tafreshi, H Soliman, DL Morse Frontiers in immunology 5, 429, 2014	54	2014
Stochasticity in the genotype-phenotype map: implications for the robustness and persistence of bet-hedging D Nichol, M Robertson-Tessi, P Jeavons, ARA Anderson Genetics 204 (4), 1523-1539, 2016	46	2016
The goldilocks window of personalized chemotherapy: getting the immune response just right DS Park, M Robertson-Tessi, KA Luddy, PK Maini, MB Bonsall, ... Cancer research 79 (20), 5302-5315, 2019	42	2019
Virtual alignment of pathology image series for multi-gigapixel whole slide images CD Gatenbee, AM Baker, S Prabhakaran, O Swinyard, RJC Slebos, ... Nature communications 14 (1), 4502, 2023	40*	2023
Agent-based methods facilitate integrative science in cancer J West, M Robertson-Tessi, ARA Anderson Trends in cell biology 33 (4), 300-311, 2023	40	2023
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023	38	2023
Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues C Gabbutt, RO Schenck, DJ Weisenberger, C Kimberley, A Berner, ... Nature biotechnology 40 (5), 720-730, 2022	38	2022
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1798, 2022	33	2022

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs